Literature DB >> 2017643

A program of outpatient parenteral antibiotic therapy for serious pediatric bacterial infections.

R Dagan1, M Einhorn.   

Abstract

A program set up in the Soroka University Medical Center, Beer Sheva, Israel, offers outpatient parenteral antibiotic therapy (OPAT) for children with serious bacterial infections. The following criteria must be met before a child is placed in this program: OPAT must be a suitable form of treatment for the infection, an appropriate drug must be available, the parents must be cooperative and well-informed, and 24-hour-a-day telephone communication and transportation between the home and hospital must be available. With use of ceftriaxone administered im, the OPAT program has shown positive results: a cure rate of 98.5% and an estimated savings of 1,334 hospital days for 140 patients over a 17-month period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2017643     DOI: 10.1093/clinids/13.supplement_2.s152

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  5 in total

Review 1.  Rational prescribing of antibacterials in hospitalised children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

2.  Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.

Authors:  R Davis; H M Bryson
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

Review 3.  Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.

Authors:  S Esposito
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 4.  Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.

Authors:  D Nathwani
Journal:  Drugs       Date:  2000       Impact factor: 9.546

5.  Parenteral-oral switch in the management of paediatric pneumonia.

Authors:  R Dagan; G Syrogiannopoulos; S Ashkenazi; D Engelhard; M Einhorn; M Gatzola-Karavelli; I Shalit; J Amir
Journal:  Drugs       Date:  1994       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.